InterPharm Laboratries Ltd

InterPharm Laboratories Ltd., founded in 1978 and today it is a subsidiary of Merck-Serono. For many years InterPharm was the largest biotechnology company in Israel, developing recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases. All the products developed at InterPharm Laboratories (Interferon b, Interleukin-6 and soluble TNF receptors) emanated from research performed at the Weizmann Institute. One product, Rebif® for the treatment of Multiple Sclerosis, is being commercially marketed.